Pet Medications Index: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Complete Up To Date Information about Dexium™.

Your Ad Here

ANADA Number: 200-312

Proprietary Name Dexium™
Sponsor Cross Vetpharm Group Ltd.
Sponsor Address Broomhill rd.
Tallaght, Dublin,    24
IRELAND
Ingredients Dexamethasone
Species Cat, no use class stated or implied
Horse, no use class stated or implied
Dog, no use class stated or implied
Cattle, no use class stated or implied
Routes of Administration Intravenous
Intramuscular
Dose Form Liquid (solution)
Drug Form Liquid (solution)
This Document (200-312) Was Pioneered By:     Schering-Plough Animal Health Corp.
Dispensing Status RX
Dosage Amount,
Indications
& Limitations

522.540 Dexamethasone injection.

Specifications: The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.

Conditions of use:

Dogs

Amount: 0.25 to 1 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Indications: The drug is indicated as an anti-inflammatory agent in dogs.

Limitations: Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Amount: 0.125 to 0.5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Indications: The drug is indicated as an anti-inflammatory agent in cats.

Limitations: Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cattle

Amount: 5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Indications: The drug is indicated as an anti-inflammatory agent in cattle.

Limitations: Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Amount: 2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.

Indications: The drug is indicated as an anti-inflammatory agent in horses.

Limitations: Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.

NAS/NRC status: These conditions are NAS/NRC-reviewed and deemed effective. Applications for these uses need not include effectiveness data as specified by 514.111 of this chapter, but may require bioequivalency and safety information.


petsmedic.org does not provide medical advice, diagnosis or treatment. The information contained on petsmedic.org site has not been scientifically or otherwise verified as to a cause and effect relationship. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment.Thank you for visitg and learning b>Dexium™.